Group 1 - The company, Easy Health (02661.HK), plans to globally offer 26.54 million shares, with 2.65 million shares available in Hong Kong and 23.89 million shares for international offering, along with an over-allotment option of 3.98 million shares [1] - The subscription period is set from December 15 to December 18, with a maximum offer price of HKD 22.68 per share, and the entry fee is approximately HKD 4,581.75 for a board lot of 200 shares [1] - The total expected fundraising amount is HKD 602 million, with a net amount of HKD 513 million, which will be used for enhancing brand awareness, increasing user engagement, strengthening partnerships, improving technology capabilities in AI and big data, medical research, working capital, and expanding into more regions and overseas markets [1] Group 2 - The company has introduced cornerstone investors, including Guangdong Hengqin Guangdong-Macao Deep Cooperation Zone Aoqin Harmony Investment Partnership (Limited Partnership), who will subscribe to approximately 4.80 million shares at the offer price [1] - Easy Health is expected to be listed on the main board by December 23, 2025, with China International Capital Corporation Hong Kong Securities Limited and China Merchants Securities (Hong Kong) Co., Limited acting as joint sponsors [1] - The company's net profits for the fiscal years 2023, 2024, and the first half of 2025 are projected to be HKD 73.645 million, HKD 10.398 million, and HKD 86.045 million, reflecting year-on-year changes of 3,673.27%, -85.88%, and 437.92% respectively [2]